Wilson Sonsini Goodrich & Rosati has advised Sofinnova Investments, Novo Holdings, and Forbion.Expedition Therapeutics, a biotechnology company specializing in therapies for novel inflammatory and respiratory diseases,…
Expedition Therapeutics Closes $165 Million Series A Financing for COPD Therapy

























